GOSHEN — Ebenezer Kio, MD, has been appointed director of clinical research at Goshen Center for Cancer Care. He coordinates strategic planning, development and compliance oversight for the center’s clinical research program. He also continues his clinical practice in medical oncology.
“Dr. Kio’s role as principal investigator and clinical research coordinator has brought innovations in cancer treatment that lead to better care worldwide,” said Randy Christophel, Goshen Health president and chief executive officer. “We value his commitment to drive our cancer studies program to develop future treatment modalities that lead to better outcomes and improved quality of life.”
Dr. Kio is a board certified, fellowship trained medical oncologist and hematologist. He joined Goshen Center for Cancer Care in 2009 and leads the medical oncology lung cancer program. Dr. Kio also specializes in drug therapies to treat cancers of the upper gastrointestinal tract, including the esophagus, stomach and pancreas.
“Our portfolio of studies is one of the most sophisticated in the region and supports research in most major types of cancer,” said Dr. Kio. “The clinical trials at our cancer center give patients early access to groundbreaking drugs and therapies that aren’t available anywhere else.”
More than 30 clinical studies are currently underway at the cancer center. They focus on a new generation of drug therapies for patients with site-specific cancers, such as lymphoma, melanoma, breast and lung cancer.
Dr. Kio earned a Bachelor of Medicine from University of Benin, Benin City, Nigeria. He received the Amgen Fellowship Award in hematology and oncology from Medical University of South Carolina, Charleston, S.C. His research and clinical interests include small and non-small cell lung cancer, non-Hodgkin lymphoma and phase 1 clinical trials across multiple tumor types.